Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anika Therapeutics, a provider of therapeutic products for tissue protection, healing and repair, has signed an exclusive agreement with Canada-based skincare company Canderm Pharma to distribute and market Elevess throughout Canada.
Subscribe to our email newsletter
Elevess is an injectable filler that reduces the appearance of lines and wrinkles on the face, and was the first hyaluronic acid-based dermal filler approved by the FDA to incorporate the anesthetic lidocaine to improve patient comfort.
Charles Sherwood, president and CEO of Anika, said: “This agreement expands the distribution of Elevess into a new and important market for Anika. Canderm Pharma has held a long-term leadership position in the Canadian dermatology market.
“They have a deep knowledge of the injectable dermal filler landscape and have established relationships with Canada’s leading cosmetic dermatologists and physicians. Our hopes are high for this product and we are eager for doctors and patients in an increasing number of geographies to experience its benefits.”